CLDI (Calidi Bio) Sotuvning yalpi rentabelligi

Calidi Biotherapeutics (CLDI) kompaniyasining rasmiy ramzlari

Calidi Biotherapeutics kompaniyasi o'ziga tegishli viroterapiya yetkazib berish platformasiga egalik qiladi, bu esa kompaniyaga narxlarni belgilash imkoniyatini beradi. Uning R&D ekotizimi rivojlanishi FDA tasdiqlari va ventura kapitali investitsiyalariga bog'liq. GURU.Markets servis grafigidagi realizatsiya marjalari 0.00 oxirgi daraja qiymatini ifodalashini ko'rsatmoqda. Saraton davolashga bo'lgan talab sikllardan mustaqil bo'lib, bu biznesga yuqori makroiqtisodiy barqarorlikni ta'minlaydi.

CLDI Calidi Bio Yalpi foyda bo'yicha rentabellik (21.02.2024 - 19.11.2026)

Calidi Biotherapeutics (CLDI) moliyaviy va bozor koʻrsatkichlari kesimi

- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:CLDI Calidi Biotherapeutics, Inc.
Calidi Bio tayyor mahsulotlari

Yalpi foyda marjasi bevosita ishlab chiqarish xarajatlarini to'lagandan keyin qoladigan tushum qismini belgilaydi. Fundamental tahlilda ushbu ko'rsatkich xarajatlarni boshqarish samaradorligini va biznesning mahsulotning har bir birligidan foyda olish qobiliyatini o'lchaydi. Tarixiy yalpi foyda marjalarini tahlil qilish orqali investor Calidi Biotherapeutics (CLDI) kompaniyasining stam hujayralarga asoslangan yuqori texnologiyali onkolitik viroterapiya dori vositalarini ishlab chiqishdagi operatsion barqarorligini baholashi mumkin.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik